SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-027722
Filing Date
2018-11-07
Accepted
2018-11-07 07:35:50
Documents
78
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xoma-10q_20180930.htm 10-Q 1890053
2 EX-10.9 xoma-ex109_282.htm EX-10.9 378542
3 EX-31.1 xoma-ex311_12.htm EX-31.1 15923
4 EX-31.2 xoma-ex312_13.htm EX-31.2 15928
5 EX-32.1 xoma-ex321_7.htm EX-32.1 7237
  Complete submission text file 0001564590-18-027722.txt   8299752

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT xoma-20180930.xml EX-101.INS 1544474
7 XBRL TAXONOMY EXTENSION SCHEMA xoma-20180930.xsd EX-101.SCH 90494
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xoma-20180930_cal.xml EX-101.CAL 44790
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xoma-20180930_def.xml EX-101.DEF 308111
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20180930_lab.xml EX-101.LAB 590410
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20180930_pre.xml EX-101.PRE 461925
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14710 | Film No.: 181164728
SIC: 2834 Pharmaceutical Preparations